Document:

SHARE PURCHASE AGREEMENT

 

This Agreement is made as of the 11th day of January
2016 (“Agreement”), by and between Jeffrey DeNunzio, with an address at 780 Reservoir Avenue, #123, Cranston, RI 02910
("Seller"), and iHealthcare, Inc., with an address at 141 NE 3rd Avenue, Miami, FL 33132 ("Purchaser").

W I T N E S S E T H:

 

WHEREAS,
Seller is the record owner and holder of 20,000,000 Common Shares, par value $.0001 par value (the “Shares”), of Opulent
ACQUISITION, INC., a Delaware corporation ("Corporation”), which Corporation has 20,000,000 shares
of common stock, issued and outstanding as of the date of this Agreement.

 

WHEREAS,
Purchaser desires to purchase 20,000,000 of the Shares from Seller, which constitutes 100% of the Corporation’s
issued and outstanding shares as of the date of this Agreement and Seller desires to sell such Shares upon the terms and conditions
hereinafter set forth;

 

NOW, THEREFORE,
in consideration of the foregoing and of the mutual covenants and agreements contained in this Agreement, and in order to consummate
the purchase and sale of the Corporation’s Shares, it is hereby agreed, as follows:

 

1. PURCHASE
AND SALE OF SHARES. Subject to the terms and conditions of this Agreement, Purchaser agrees to purchase at the Closing and
the Seller agrees to sell to Purchaser at the Closing, 20,000,000 of Seller’s Shares for a total price of twenty five thousand
U.S. dollars and no cents (USD $25,000.00) (the “Purchase Price”).

 

2. GOOD
FAITH DEPOSIT. There is no initial deposit for the transaction. The amount is agreed
by the purchaser to be paid in full as described below.

 

3. CLOSING.
The purchase and sale of the Shares shall take place on or before January 30, 2016; at such time and place as the Purchaser and
Seller mutually agree upon orally or in writing (which time and place are designated as the “Closing”). At Closing,
Purchaser shall deliver to Seller, in cash, by wire transfer to an account to be designated by Seller, the balance of the Purchase
Price in the amount of twenty five thousand U.S. dollars and no cents (USD $25,000.00), and Seller will immediately deliver the
following to Purchaser: (A) the certificate representing the Shares transferred hereunder, duly endorsed for transfer to the Purchaser
or accompanied by appropriate stock powers, (B) the original of the Certificate of Incorporation and bylaws, (C) all corporate
books and records (including all accounting records); and (D) written resignations of incumbent directors and officers of the Corporation.

 

Post-closing duties by Seller. Seller
agrees to perform following duties for Purchaser after the Closing:

 

	 	a.	 8-K filing and or super 8K filing

 

	 	b.	Change of Company Name and Resignation of present Director. Appointment of new Director.

 

	 	c.	Schedule 14F-1 & Schedule 13D filing.

 

 

Post-closing assistances by Seller.
Seller agrees to perform following assistances for Purchaser after the Closing:

a. Appointment of market maker

b. Appointment of transfer
agent

c. Achieving of CUSIP Number
for a fee

d. Appointment of securities
attorney (if necessary)

e. S-1 or other SEC filing
for a fee

f. Form-211 filing to FINRA
for a fee

g. DTC Market Participant for
a fee

 

 

 

 4. REPRESENTATIONS
AND WARRANTIES OF SELLER. Seller, as sole director and officer of Corporation, hereby represents and warrants to Purchaser
that:

 

(i) Corporation
is a corporation duly organized and validly existing and in good standing under the laws of the State of Delaware and has the corporate
power and authority to carry on the business it is now being conducted. Corporation and/or Seller do not require any consent and/or
authorization, declaration or filing with any government or regulatory authority to undertake any actions herein;

(ii) Corporation
has filed with the United States Securities and Exchange Commission (‘SEC”) a registration statement on Form 10-12G,
as amended. The CIK No. for the corporation is 0001634291.

(iii) Corporation
has timely filed and is current on all reports required to be filed by it pursuant to Sections 13 and 15 of the Securities Exchange
Act of 1934.

(iv) Corporation
is newly formed with no financial information available other than the financial information included in its SEC filings;

(v) There
are no legal actions, suits, arbitrations, or other administrative, legal or governmental proceedings threatened or pending against
the Corporation and/or Seller or against the Seller or other employee, officer, director or stockholder of Corporation. Additionally,
Seller is not aware of any facts which may/might result in or form a basis of such action, suit, arbitration or other proceeding
on any basis whatsoever;

(vi) The
Corporation has no subsidiaries or any direct or indirect ownership interest in any other corporation, partnership, association,
firm or business in any manner;

(vii) The
Corporation and/or Seller does not have in effect nor has any present intention to put into effect any employment agreements, deferred
compensation, pension retirement agreements or arrangements, options arrangements, bonus, stock purchase agreements, incentive
or profit–sharing plans;

(viii) No
person or firm has, or will have, any right, interest or valid claim against the Corporation for any commission, fee or other compensation
in connection with the sale of the Shares herein as a finder or broker or in any similar capacity as a result of any act or omission
by the Corporation and/or Seller or anyone acting on behalf of the Corporation and/or Seller;

(ix) The
business and operation of the Corporation has and will be conducted in accordance with all applicable laws, rules, regulations,
judgments. Neither the execution, delivery or performance of this Agreement (A) violates the Corporation’s by-laws, Certificate
of Incorporation, Shareholder Agreements or any existing resolutions; and, (B) will cause the Corporation to lose any benefit or
any right or privilege it enjoys under the Securities Act (“Act”) or other applicable state securities laws;

(x) Corporation
has not conducted any business and/or entered into any agreements with third-parties;

(xi) This
Agreement has been duly executed and delivered by Seller constitutes a valid and binding instrument, enforceable in accordance
with its terms and does not conflict with or result in a breach of or in violation of the terms, conditions or provisions of any
agreement, mortgage, lease or other instrument or indenture to which Corporation and/or Seller a party or by which they are bound;

(xii) Seller
is the legal and beneficial owner of the Shares and has good and marketable title thereto, free and clear of any liens, claims,
rights and encumbrances;

(xiii) Seller
warrants that the Corporation being transferred shall be transferred with no liabilities and little or no assets, and shall defend
and hold Purchaser and the Corporation harmless against any action by any third party against either of them arising out of, or
as a consequence of, any act or omission of Seller or the Corporation prior to, or during the closing contemplated by this contract
of sale; and

(xiv) Seller
will cause all current officers and directors of the Corporation to resign at the Closing.

  

5. REPRESENTATIONS
AND WARRANTIES OF PURCHASER. Purchaser hereby represents and warrants to Seller that:

 

(i) Purchaser
has the power and authority to execute and deliver this Agreement, to perform his obligations hereunder and to consummate the transactions
contemplated hereby. This Agreement has been duly executed and delivered by Purchaser and constitutes a valid and binding instrument,
enforceable in accordance with its terms;

(ii) The
execution, delivery and performance of this Agreement is in compliance with and does not conflict with or result in a breach of
or in violation of the terms, conditions or provisions of any agreement, mortgage, lease or other instrument or indenture to which
Purchaser is a party or by which Purchaser is bound;

(iii) At
no time was Purchaser presented with or solicited by or through any leaflet, public promotional meeting, television advertisement
or any other form of general solicitation or advertising; and,

(iv) Purchaser
is purchasing the Shares solely for his own account for the purpose of investment and not with a view to, or for sale in connection
with, any distribution of any portion thereof in violation of any applicable securities law.

(v) The
Purchaser is an "accredited investor" as defined under Rule 501 under the Securities Act.

(vi) Purchaser
hereby agrees that such shares are restricted pursuant to Rule 144 and therefore subject to Rule 144 resale requirements.

 

6. NOTICES.
Notice shall be given by email at the most recent address last received by Seller from Buyer or by Buyer from Seller. Notice
may also be given by certified mail, return receipt requested, the date of notice being deemed the date of postmarking. Notice,
unless either party has notified the other of an alternative address as provided hereunder, shall be sent to the address as set
forth herein:

 

Seller:

 

Jeffrey DeNunzio,
President and Director

Opulent Acquisition,
Inc.

780 Reservoir Avenue,
#123

Cranston, R.I. 02910

FAX: (401) 633-7300

Email: jeff@vfinancialgroup.com

 

Purchaser:

 

iHealthcare, Inc.

141 NE 3rd
Avenue, 9th Floor

Miami, FL 33132

Phone: (305) 336-5608

Email: noel@healthcaresystems.com 

 

7. GOVERNING
LAW. This Agreement shall be interpreted and governed in accordance with the laws of the State of Delaware. The parties herein
waive trial by jury. In the event that litigation results or arise out of this Agreement or the performance thereof, the parties
agree that the prevailing party is entitled to reimbursement for the non-prevailing party of reasonable attorney’s fee, costs,
expenses, in addition to any other relief to which the prevailing party may be entitled.

 

8. CONDITIONS
TO CLOSING. The Closing is conditioned upon the fulfillment by the Seller of the satisfaction of the representations and warranties
made herein being true and correct in all material respects as of the date of Closing.

 

9. SEVERABILITY.
In the event that any term, covenant, condition, or other provision contained herein is held to be invalid, void or otherwise unenforceable
by any court of competent jurisdiction, the invalidity of any such term, covenant, condition, provision or Agreement shall in no
way affect any other term, covenant, condition or provision or Agreement contained herein, which shall remain in full force and
effect.

 

10. ENTIRE
AGREEMENT. This Agreement contains all of the terms agreed upon by the parties with respect to the subject matter hereof. This
Agreement has been entered into after full investigation.

 

11. INVALIDITY.
If any paragraph of this Agreement shall be held or declared to be void, invalid or illegal, for any reason, by any court of competent
jurisdiction, such provision shall be ineffective but shall not in any way invalidate or effect any other clause, Paragraph, section
or part of this Agreement.

 

12. GENDER
AND NUMBER; SECTION HEADINGS. Words importing a particular gender mean and include the other gender and words importing a singular
number mean and include the plural number and vice versa, unless the context clearly indicated to the contrary. The section and
other headings contained in this Agreement are for reference purposes only and shall not affect the meaning or interpretation of
this Agreement.

 

13. AMENDMENTS.
No amendments or additions to this Agreement shall be binding unless in writing, signed by both parties, except as herein otherwise
provided.

 

14. ASSIGNMENT. Neither
party may assign this Agreement without the express written consent of the other party. Any agreed assignment by the Seller shall
be effectuated by all the necessary corporate authorizations and governmental and/or regulatory filings.

 

15. CLOSING
DOCUMENTS. Seller and Purchaser agree, at any time, to execute, and acknowledge where appropriate, and to deliver any and all
documents/instruments, and take such further action, which may necessary to carry out the terms, conditions, purpose and intentions
of this Agreement. This paragraph shall survive the Closing.

 

16. EXCLUSIVE
AGREEMENT; AMENDMENT. This Agreement supersedes all prior agreements or understandings among the parties with respect to its
subject matter with respect thereto and cannot be changed or terminated orally.

 

17. FACSIMILE
SIGNATURES. Execution of this Agreement and delivery of signed copies thereof by facsimile signatures from the parties hereto
or their agents is acceptable to the parties who waive any objections or defenses based upon lack of an original signature.

 

18. PUBLICITY.
Except as otherwise required by law, none of the parties hereto shall issue any press release or make any other public statement,
in each case relating to, connected with or arising out of this Agreement or the matters contained herein, without obtaining the
prior approval of the other to the contents and the manner of presentation and publication thereof.

 

 

IN WITNESS WHEREOF,
and intending to be legally bound, the parties hereto have signed this Agreement by their duly authorized officers the day and
year first above written.

 

 

 

 

/s/ Noel Mijares

IHEALTHCARE, INC.

By Noel Mijares, its CEO

(PURCHASER)

 

/s/ Jeffrey DeNunzio

Jeffrey DeNunzio

 

(SOLE SHAREHOLDER)RESIGNATION
LETTER

 

January
14, 2016

 

To
the Shareholders and Board of Directors of

Opulent
Acquisition, Inc.,

 

Gentlemen:

 

This
letter serves as notice that as of the date hereof, I hereby resign from my position as  Chief Executive Officer, Chief
Financial Officer, President, Director, Secretary, and Treasurer,  of  Opulent Acquisition, Inc.
(the “Corporation”). My resignation is not the result of any disagreement with the Corporation on any matter
relating to its operation, policies (including accounting or financial policies) or practices.

 

Sincerely,

/s/
Jeffrey DeNunzio

Jeffrey
DeNunzio

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00253-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00253-of-00352.parquet"}]]